spacer
home > pmps > autumn 2017 > making the switch
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Making the Switch

The global pharmaceutical manufacturing sector revenue is estimated to increase to around $1,226 billion by 2018. To remain competitive in such a large market, these organisations must optimise processes to create low-expense products without compromising quality. The adoption of continuous manufacturing will offer the industry many benefits.

Pharma production is a well-established sector that provides high-quality and affordable medication to the population. However, manufacturers often rely on older processes rather than adapting to meet the growing needs of consumers.

Traditionally, batch manufacturing produces the majority of drugs sold worldwide a method that isolates each process. Workers will handle the product at each stage, sending it to be tested in laboratories before the next step. While this works effectively, receiving the final item may take months. Companies are looking for new solutions to reduce costs, environmental impact and development time.

In the boom of Industry 4.0, many sectors, such as chemicals and gas, have implemented more advanced technology to optimise production. Integrated automation systems can streamline an assembly line to efficiently create medication and devices frequently, with little human interaction. Continuous manufacturing is an advancement that developers should utilise to reap the same benefits as these industries.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Jonathan Wilkins is Marketing Director at EU Automation and is also one of the most prolific Industry 4.0 writers in the industrial automation sector. A professional brand advocate and commercial marketing strategist, he has been part of the company since its humble beginnings in 2009 and has over a decade of experience in marketing.
spacer
Jonathan Wilkins
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

2019 IPEC Europe Annual Excipients Forum, Malta, 31 January

Join NSF at this dynamic conference in Malta on the 31st January 2019, recognised to be one of the key events for pharmaceutical excipients in Europe.
More info >>

White Papers

Planning the Execution of a Viral Clearance Study

Eurofins BioPharma Product Testing

Viral clearance studies are a necessary component of any regulatory submission for clinical trials or commercial product approval for all biopharmaceutical products. These studies are performed to evaluate the capability of the purification process to remove or inactivate viruses that could potentially contaminate the starting material. They are complex studies that require substantial financial and personnel resources, as well as specialized scientific expertise to perform. As such, viral clearance studies are often performed at a qualified contract testing laboratory rather than in-house. When multiple parties are involved in this process, clear communication and a comprehensive understanding of the approach and timeline is critical.
More info >>

 
Industry Events

14th Annual Biomarkers Congress

21-22 February 2019, Manchester Central Convention Complex, UK

Oxford Global is proud to present for the 14th year our flagship Biomarkers Congress, taking place 21 22 February 2019 in Manchester, UK. An updated programme ensures you will benefit from talks on the latest strategies and technologies impacting growth in the biomarker industry.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement